Abstract
A group of class I selective HDAC inhibitors were derived previously, with inhibitory preference of HDAC1 and HDAC3 over HDAC2. Molecular docking and molecular dynamic simulation approaches were performed to elucidate the structural basis of inhibitor’s selectivity between HDAC2 and HDAC3. Superimposition of the rigid docked structures showed that residues in the active sites of both receptors are identical, and the inhibitor (D18) has similar binding patterns in both sites. Results of the flexible docking suggested that strong hydrophobic interactions between molecule D18 and Phe199 play significant role in the selectivity. The interactions were verified to be stable by further molecular dynamic simulation processes.
Keywords: HDAC, inhibitor, selectivity, flexible docking, molecular dynamic simulation.
Letters in Drug Design & Discovery
Title:Molecular Simulation of HDAC1/3 Inhibitor: Insights into the Structural Basis of Selectivity
Volume: 13 Issue: 1
Author(s): Lei Zhang and Lihui Zhang
Affiliation:
Keywords: HDAC, inhibitor, selectivity, flexible docking, molecular dynamic simulation.
Abstract: A group of class I selective HDAC inhibitors were derived previously, with inhibitory preference of HDAC1 and HDAC3 over HDAC2. Molecular docking and molecular dynamic simulation approaches were performed to elucidate the structural basis of inhibitor’s selectivity between HDAC2 and HDAC3. Superimposition of the rigid docked structures showed that residues in the active sites of both receptors are identical, and the inhibitor (D18) has similar binding patterns in both sites. Results of the flexible docking suggested that strong hydrophobic interactions between molecule D18 and Phe199 play significant role in the selectivity. The interactions were verified to be stable by further molecular dynamic simulation processes.
Export Options
About this article
Cite this article as:
Zhang Lei and Zhang Lihui, Molecular Simulation of HDAC1/3 Inhibitor: Insights into the Structural Basis of Selectivity, Letters in Drug Design & Discovery 2016; 13 (1) . https://dx.doi.org/10.2174/1570180812666150630183816
DOI https://dx.doi.org/10.2174/1570180812666150630183816 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Histone Deacetylase Inhibitors In Inflammatory Disease
Current Topics in Medicinal Chemistry MGBG in Combined Anticancer Chemotherapy
Letters in Drug Design & Discovery Antisense Therapy for Cardiovascular Diseases
Current Pharmaceutical Design Structural and Functional Role of Gly281 in L-asparaginase from Erwinia carotovora
Protein & Peptide Letters Review of Clinic Trials: Agents Targeting c-Met
Reviews on Recent Clinical Trials Self-Renewal Versus Differentiation in Hematopoietic Stem and Progenitor Cells: A Focus on Asymmetric Cell Divisions
Current Stem Cell Research & Therapy Drug Targeting Strategies for Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala
Current Neuropharmacology Reviewing Colchicaceae Alkaloids – Perspectives of Evolution on Medicinal Chemistry
Current Topics in Medicinal Chemistry Natural Products Based Anticancer Agents
Mini-Reviews in Organic Chemistry A Tour of Unsupervised Deep Learning for Medical Image Analysis
Current Medical Imaging Pharmacogenomics – Implications in the Development of HIV-Associated Brain Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nutrition Support of Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Current Nutrition & Food Science Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Current Cancer Drug Targets Antineoplastic Chemotherapy Induced QTc Prolongation
Current Drug Safety Designed Multiple Ligands for Cancer Therapy
Current Medicinal Chemistry Th17 Cells in Airway Diseases
Current Molecular Medicine A Filter Based Feature Selection Algorithm Using Null Space of Covariance Matrix for DNA Microarray Gene Expression Data
Current Bioinformatics Recent Progress in Therapeutic and Diagnostic Applications of Lanthanides
Mini-Reviews in Medicinal Chemistry Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors
Anti-Cancer Agents in Medicinal Chemistry